
Stanford doctors discuss new lung cancer screening guidelines, increasing incidence in non-smokers, and latest treatment approaches including minimally invasive surgery, targeted therapies, and precise radiation therapy.

Explore the latest surgical and nonsurgical lung cancer treatments, including staging, targeted therapies, and immunotherapy, with UCLA experts Dr. Lee and Dr. Goldman.

Exploring innovative approaches to accelerate rare cancer treatments through immunotherapy, data sharing, and novel trial designs. Experts discuss challenges and promising advancements in the field.

Explore cutting-edge techniques for image-guided cellular control in living organisms with Professor Christopher Contag, advancing the field of quantitative health science and engineering.

Explore cutting-edge lung cancer treatments, focusing on immunotherapy and targeted approaches, with insights from Stanford Cancer Institute researcher Dr. Joel Neal.

Explore clinical research in cancer genomics and its impact on treatment approaches, including personalized medicine, tumor profiling, and targeted therapies.

Explore advancements in ovarian cancer diagnosis and treatment, including specialized approaches based on cancer location and cellular anatomy, with insights from Dr. Oliver Dorigo of Stanford University.

Khám phá gánh nặng ung thư phổi ở người châu Á, các yếu tố nguy cơ và tiến bộ trong sàng lọc, phát hiện sớm và điều trị cá nhân hóa với liệu pháp nhắm mục tiêu và miễn dịch.

Explore advancements in lung cancer treatment, including targeted therapies, molecular profiling, and clinical trials. Learn about evaluation methods, systemic approaches, and emerging strategies for different cancer stages.

Explore risk heterogeneity and targeted therapies for familial hypercholesterolemia, showcasing precision medicine approaches in cardiovascular health management.

Comprehensive overview of hemoptysis, covering definition, diagnosis, physical examination, lab studies, and treatment options. Equips healthcare providers with essential knowledge for managing this condition.

Explore cancer's evolutionary origins, its presence across species, and modern treatment approaches. Gain insights into cellular behavior, genetic mutations, and the ongoing battle against this ancient disease.

Explore ovarian cancer development, risk factors, and therapies, with a focus on PARP inhibitors. Dr. Goodman discusses modern cases, genetic factors, and treatment approaches for this complex disease.

Explore genomic instability in cancer, focusing on HRD and PARP inhibitors. Learn about diagnostic approaches for identifying individuals with Homologous Recombination Deficiency.

Explore targeted therapies for non-Hodgkin lymphoma, including diagnostic techniques and clinical trials to optimize treatment with fewer side effects.

Explore PCSK9 inhibitors as a targeted treatment for hypercholesterolemia with Dr. Alan S. Brown. Learn about this innovative approach to managing high cholesterol levels and its potential impact on cardiovascular health.

Explore advancements in lung cancer treatment, including targeted therapies and immunotherapy. Learn about genetic diagnostics, improved survival rates, and emerging strategies for patient care in this evolving field.

Explore the latest advancements in antibody-drug conjugates (ADCs) for treating non-small cell lung cancer, focusing on their efficacy, safety, and potential to revolutionize NSCLC therapy.

Explore updated guidelines for treating relapsed/refractory multiple myeloma, enhancing patient care with the latest therapeutic approaches and clinical insights.

Experts discuss progress in cancer research and treatment over the past 50 years, highlighting advancements, current challenges, and future prospects in the fight against various forms of cancer.

Exploring groundbreaking cancer research, from early detection using microRNAs to organ regeneration through bioprinting, while emphasizing the importance of compassionate care for patients and their families.